Canada Over The Counter (OTC) Drugs Market Analysis Report 2022 to 2030

Canada OTC
Market Analysis
A sample report on
www.insights10.com
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2021 – 2030F)

This report presents a strategic analysis of the Canada OTC
Pharmaceutical market and a forecast for its development in the medium
and long term. It provides a comprehensive overview of the market value,
dynamics, segmentation, characteristics, main players, trends and insights,
growth and demand drivers, challenges & future outlook, etc. This is one of
the most comprehensive reports about the Canada OTC Pharmaceutical
market, and offers unmatched value, accuracy, and expert insights

Table of
Contents
• Market Overview
• Growth Drivers & Restraints
• Market Segmentation
• Major Market Share
• Competitive Landscape
• Key Company Profiles
• Notable Deals
• Healthcare Policies & Regulatory Framework
• Factors Driving Future Growth
• Strategic Recommendations

4 A Sample Report on Canada Over the Counter (OTC) Market I Confidential
Table of Contents
1. Canada Over the Counter (OTC) Market Overview……………………………..…………..………………….......................7
1.1 Introduction
1.2 Market size and forecast
1.3 Adoption of OTC drugs continues to rise
1.4 Key Aspects of OTC Market
2. Market Growth Drivers and Restraints …………………………………………………………………….…………………….12
2.1 Market Growth Drivers
2.1.1 Rising demand for treatments of minor ailments
2.1.2 Increasing number of health-conscious customers
2.1.3 Product Innovation
2.1.4 Switching of Rx drugs to OTC
2.2 Market Restraints
2.2.1 Irrational use of medicines due to self diagnosis/misdiagnosis
2.2.2 Drug abuse, possibility of drug addiction

Table of Contents (continued)
3. Over the counter (OTC) Market Segmentation………………..……………………………………..…..……….….……..…..19
3.1 By drug type
3.2 By distribution channel
4. Canada Over the Counter (OTC) Major products Market Share ………………………………………………….….....…..24
4.1 Market Analysis, Insights and Forecast - By Revenue
5. Competitive Landscape……………….…………………………………………………………………………………..….…….26
5.1 Major Players Revenue
6. Key Company Profiles (Company Overview, Product & Services, Strategies & Financials ) ….………………...…...…....28
6.1 Johnson and Johnson
6.2 Pfizer Inc
6.3 Novartis
6.4 Bayer AG
6.5 Sanofi
7. Canada OTC market: Key notable deals ………………………………….…………………………………………….……....38

Table of Contents (continued)
8. Healthcare Policies and Regulatory Landscape………………………………….………………………………….……..…..40
8.1 Regulatory Framework of Gram-Negative Infection Therapeutic Market
9. Future Development Growth………………………………………………………………………………………….……..….....42
9.1 Future Opportunities
10. Strategic Recommendations.……………………………………………………………………………………….……..…….44

Canada OTC Pharmaceutical Market Analysis
1. Overview

1.1 Introduction
▪ The Canadian over the counter drugs market is projected to grow at a notable rate. This is primarily attributed to the recent product
launches, inclination of consumers from prescription medicine to over the counter products, increasing number of diseases, and rising
awareness regarding self-medication
▪ About one in five Canadians experience chronic pain. Chronic pain has a significant impact on an individual’s physical and mental
health, often preventing them from undertaking everyday activities, as per the Canadian Pain Society 2019
▪ As per the Chronic Pain Association of Canada (CPAC) 2019 survey, between 17-31% of people has reported chronic pain. 50% of
hospitalized patients also reported acute pain of moderate to severe intensity, which has increased the demand for OTC medications
Sample

1.2 Market Size & Forecast Overview
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
xx
XX
Canada Over the Counter (OTC) Market Size ($Bn) 2021-2030F Key Analysis
▪ Over the Counter (OTC) Market size in Canada
was valued at more than $XX Bn in 2020 and is
expected to expand at a compound annual growth
rate (CAGR) of xx% from 2021 to 2030
▪ Millions of Canadians visits pharmacies each year
to purchase OTC remedies. These products can
help treat a wide range of minor complaints, and
no prescription is required to buy them
Sample

1.3 Adoption of OTC drugs continues to rise
Affordability
Telemedicine
Vitamins &
Supplement
Selfcare
Lowers the cost of treatment and eliminates the cost of physician meetings,
making it more affordable to all patient classes
With growing demand for OTC vitamins & dietary tablet supplements, sales are
forecasted to reach over $XXB by 2031 in Canada
~XX% of Canadian consumers believe what they eat impacts their physical
health, with nearly two-thirds (XX%) agreeing it also affects their emotional
wellbeing, approximately 19% of Canadians manage the minor ailments by
themselves
Smartphone users are expected to rise to XXM in 2024 from which many
opportunities are created through apps that help users better with understanding
and treatment
High penetration of smartphones and access to high-speed internet
connectivity will paved the way for telemedicine and online drugs sales,
resulting in the growth of OTC healthcare market
Driving forces for OTC drugs market in Canada
Sample

1.4 Key aspects of Canada OTC market
▪ Private label OTC sales in Canada was about XX% in 2019
▪ Stores often sell private label products at lower price than manufacturing product leading increase of popularity of OTC
drugs
▪ Market share of private label products are expanding in all therapeutic categories including smoking cessation, pain,
cough and cold, and gastrointestinal remedies
▪ Recent studies show, reductions in annual
prescription drug expenditure due to, XX% of total
revenue is generated through online sales of
OTC drugs
▪ Growth drivers include consumer’s desire for
convenience, multiple product options, and the
ability to price compare
▪ Amazon launched Basic Line with partnership with
Perrigo, the largest OTC private label manufacturer
Key
Aspect
s
Key
Aspects
▪ More than XX prescription drugs are
converted into OTC products by FDA
in past 30 years
▪ New strategies of Rx-to-OTC is
being developed by pharma giants
Sample
Rx-to-OTC Switches
Online Sales
Private Labels
Sample

2. Growth Drivers & Restraints

2. Market Growth Drivers and Restrains
Switching of Rx Drugs to
OTC
Product Innovation
Increasing number of
health-conscious
consumers
Rising demand for
treatments of minor
ailments
Irrational use of medicines
due to self-diagnosis /
misdiagnosis
Drug abuse, possibilities of
drug addiction
1
2
4
3
2
1

2.1 Market Growth Drivers
1.
1
1.
4
1.
2
2.1.1 Rising demand for treatments of minor ailments
▪ Ontario is in the process of establishing a plan for allowing pharmacists to prescribe for minor ailments. Eight
provinces across Canada already allow pharmacist prescribing for minor ailments, and the style of billing varies
province to province
▪ Canadian estimates show that 10 to 30% of physician consultations are for minor ailments. This has led to increased
non-prescription recommendations, facilitating self care
Sample

Market Growth Drivers (continued)
2.
1
2.
4
2.3
2.
2
2.1.2 Increasing Number of Health-Conscious Consumers
▪ More than two-third of the Canadian population is making conscious efforts to improve their health
▪ According to research, more than half of Canadian consumers are proactively trying to lose weight to take charge of
their health
Sample

2.1.3 Product Innovation
▪ Several companies have been opting for several innovative marketing strategies, to capture a market share as high as
possible
▪ Key industry players are involved in R&D to develop and market new OTC drugs for various health conditions
▪ Moreover, in 2020, the launch of Terpacan OTC drug for back and muscle pain and hemorrhoids in Canada after
receiving approval of Health Canada by Tetra Bio-Pharma has also been driving the overall market growth
Sample

2.1.4 Switching of Rx Drugs to OTC
▪ Several companies have been opting for several innovative marketing strategies, to capture a market share as high as
possible
▪ Key industry players are involved in R&D to develop and market new OTC drugs for various health conditions. For
instance, In 2019, Innovus Pharma launched Xyralid Suppositories in Canada, for the reduction of swelling or
inflammation of hemorrhoidal tissues and provides pain relief from burning, itching and discomfort
Sample

2.2 Market Restraints
2.2.1 Irrational use of medicines due to self-
diagnosis / misdiagnosis
2.2.2 Drug abuse, possibilities of drug
addiction
Sample
▪ Consumption of wrong medication due to
incorrect self-diagnosis or misdiagnosis may
lead to severe complications and is one of
the key factor that may hinder the market
growth
▪ Many OTC cold and cough products have led
to medication errors and cause adverse
effects on the patient’s body
▪ All OTC medication carries risk, primarily
risk of tolerance and dependence by
OTC painkillers
▪ High and more frequent doses of OTC drugs
can lead to phycological dependence
Sample

3. Market Segmentation

Canada Over the Counter (OTC) Market Segmentation
Market
Restraints
Canada Over the
Counter (OTC)
Market Segmentation
By Drug Type
By Distribution Channel Type

Snapshot of OTC Market Segmentation
By Drug Type By Distribution Channel
▪ Online Channels
▪ Offline Channels
▪ Analgesics
▪ Cold & Cough Remedies
▪ Vitamins & Minerals
▪ Digestive & Intestinal Remedies
▪ Skin Treatment
▪ Hand Sanitizer

3.1 Market Segmentation: By Drug Type
Key Summary
Canada Over the Counter (OTC) Market Share by Drug Type
2022
2021 2022F
Analgesics
Vitamins & Minerals Skin
Treatment
2023F 2024F 2025F
▪ The analgesics segment held the largest share of
the market in 2021, whereas the hand sanitizer
segment is anticipated to register the highest
CAGR in the market during the forecast period
▪ Growing number of head and back pain cases
coupled with increasing number of new product
launches in this segment contribute towards
Analgesics market growth
▪ The use of vitamins, minerals, and other nutritional
supplements has been increasing, due to their
easy availability over the counter
Cold & Cough Remedies
Digestive & Intestinal Remedies
Hand Sanitizer
Sample
Sample

3.2 Market Segmentation: By Distribution Channel
Key Summary
Canada Over the Counter (OTC) Market Share by Distribution
Channel, 2022
▪ The hospital pharmacies are growing at a high
rate, as Medical practices, hospitals, and their
patients are increasingly obtaining over the
counter drugs through hospital pharmacies
▪ In today's scenario, the public is increasingly
adopting retail pharmacy as a one-stop-shop to
buy all the OTC products which drives the growth
of offline pharmacies in Canada
2021 2022F 2023F 2024F 2025F
Offline Online
Sample
Sample

4. Major Market Share

25 A Sample Report on Global Gram-Negative Infection Therapeutic Market I Confidential
Top Brands in Canada Over the Counter (OTC)
Therapeutic Market
4.1 Major Canada Over the Counter (OTC) Products Market Share
Key Insights
Canada Over the Counter (OTC) Major Products Market
Share
0
1
2
3
4
5
6
7
8
9
0 1 2 3 4 5
Brand 1 Brand 2 Brand3 Brand 4
Sample

5. Competitive Landscape

5.1 Competitive Landscape: Key Players Revenue
(Current and Forecasted)
Major Market Revenue of Physiotherapy Therapeutic Companies ($Bn)
2021 2022F 2023F 2024F 2025F
Johnson and Johnson Inc $ 93.7 $XX $XX $XX $XX
Pfizer Inc. $ 81.3 $XX $XX $XX $XX
Novartis $XX $XX $XX $XX $XX
Bayer AG $XX $XX $XX $XX $XX
GlaxoSmithKline plc $XX $XX $XX $XX $XX
Sample

6. Key Company Profiles

6.1 Johnson and Johnson Inc
Company Profile Company Name: Johnson and Johnson Inc
Year of Establishment: 1886
Headquarter: New Jersey, USA
Revenue: $93.7B
Website: https://www.jnj.com/
▪ Johnson & Johnson is the largest and most broadly based
healthcare company in the world. It is specializes in the
areas of health care, medical devices & diagnostics,
pharmaceuticals and consumer packaged goods
Sample

6.2 Pfizer Inc
Company Profile Company Name: Pfizer Inc
Headquarter: New York, United States
Revenue: $81.3B
Website: https://www.pfizer.com/
▪ Pfizer Inc. is a biopharmaceutical company that discovers,
develops, manufactures, and sells healthcare products,
worldwide
Sample

Pfizer Inc (Continued)
Breakdown of net revenue by segment, 2022
Revenues ($Bn), 2021-2030F
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn
Sample

6.3 Novartis
Company Name: Novartis
Headquarter: Basel, Switzerland
Revenue: $51.6B
Website: https://www.novartis.in/
Sample
Company Profile
▪ Novartis AG is a global pharmaceutical company, by both
market capitalization and sales. It has two business
operating divisions: Innovative Medicines and Sandoz
(generics)

Novartis (Continued)
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn
Sample

6.4 Bayer AG
Company Name: Bayer AG
Headquarter: Leverkusen, Germany
Revenue: $48.9B
Website: https://www.bayer.com
Sample
▪ Bayer is a Life Science company with a more than 150-
year history and core competencies in the areas of health
care and agriculture
▪ The pharmaceutical division focuses on prescription
products, especially for cardiology and women’s
healthcare, and on specialty therapeutics in the areas of
oncology, hematology and ophthalmology
Company Profile

Bayer AG (Continued)
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn
Sample

6.5 Sanofi
Company Name: Sanofi
Headquarter: Paris, France
Revenue: $41.9B
Website: https://www.sanofi.com/
Company Profile
▪ Sanofi SA is a global healthcare company engaged in the
research, development, manufacture, and marketing of
therapeutic solutions
Sample

Sanofi (Continued)
Analysis
1 2 3 4
XX
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
$XX Bn
Sample

7. Notable Deals

Sanofi signed an agreement with Roche for the exclusive OTC rights to
Tamiflu
Sanofi Roche
Sample Sample Sample

8. Healthcare Policy and Regulatory Landscape

8.1 Regulatory Framework of Canada OTC Market
Non-prescription drugs require a valid Drug Identification Number (DIN) to be sold in Canada. On a product label,
this number indicates the drug has met the requirements for safety, quality and effectiveness
The Food and Drug Regulations, Natural Health Products Regulations, and Medical Devices Regulations make up
the general regulatory framework
Health Canada is the federal authority responsible for regulating pharmaceutical drugs, biologicals, and medical
devices for human use
Sample
Sample

9. Future Opportunities

9.1 Key developments in Canada OTC market
Dell Tech
▪ The Canadian over-the-counter product registration process
is time-consuming and complex. Registrants must have
labels reviewed against the various monographs and
formulations reviewed against the Natural Health Products
Ingredients Database (NHPID)
Harness the spirit of experimentation to maximize RWE
potential for OTC
▪ Real world evidence (RWE) has been a driving force in
prescription drug development and commercial decision
making for years, but it has yet to take hold in the over the
counter (OTC) medicines landscape

10. Strategic Recommendations

10. Wayforward
1
2
3
5
4
Increasing Demand
Growing demand for OTC
drugs . Every year the
demand will increase in
upcoming years
Affordability
As there is a lack of awareness
among people for blood
donations, government and
hospitals are rolling out schemes
to attract donors like paid
donations
Availability
Major OTC drugs were sold to
retail drug stores and hospitals
from where the consumer can
buy easily Government funding
and Reimbursement
Territorial
governments are
responsible for the administration
of their own publicly funded
prescription benefit programs
Future Opportunities
Understanding the epidemiologic
aspects of any public health
problem in terms of its dynamic
(prevalence), distribution, and
determinants is critical for
prevention and control

47 A Sample Report on Canada Over The Counter (OTC) Market I Confidential
Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)

Analysis Methodology
Our Analysis Methodology involves three critical stages:
Primary
Research
Secondary
Research
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Data Collection
Market Data Analysis
& Statistical Model
Interpretation &
Presentation

Data Triangulation & Data Validation
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary

Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2021 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

2021
2022-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (5 working days) with
purchase. We will provide you with data that is
currently not a part of our scope as a part of
customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period

The report is prepared
using a proven
methodology and
insightful research
Reliable
The data is prepared by
a team of highly qualified
& experienced research
analysts & vetted by our
local associates
Expert-verified
Allowing you to
confidently make
smarter business
and strategic
decisions
Real
Covers everything you
would need to know
about the market
including market size,
competitive analysis &
much more
Comprehensive
You do not have to be a
market expert to
understand what really is
happening on the market
and how it works
Easy to read
What kind of Data is Presented
in this Report?
This report presents data, which is:
www.insights10.com

www.insights10.com
A large database of over 30,000 syndicated market
research reports in pharmaceuticals and
healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Lifesciences Market
Research Reports you
can trust

Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
Get Insights to take
informed Business
Decisions
www.insights10.com

Market Research Reports
across various domains of healthcare
Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Pharmaceuticals
(Diseases & Drugs)
Digital
Health
Medical
Devices

Our
Services
1
2
3
4
5
6
10
9
8
7
Market Research Reports
Customized Reports
Primary Research
Database Services
Full-Time Engagement
Conference Coverage
Competitive Intelligence
Strategic Research Projects Regulatory Compliance
Report Subscription Services

Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis
www.insights10.com

Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players
www.insights10.com

Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions

Mukesh is an engineering graduate
with an MBA in Marketing. He is a
seasoned healthcare market
research & marketing professional
with a progressive experience of over
20 years in Life Sciences, Pharma
and Medical Device sectors . With an
in-depth understanding of primary
research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare
& completed several research
projects across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Purav is a physician and an
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Dhruv Joshi is an engineer and has done
Masters in Hospital Administration with
over 4 years of experience in the
healthcare and life science industry. He
has gained proficiency in market
research, market assessment, and
developing insights from it. He has
worked on various consulting projects
across different geographies including
Asia, Europe, US, MENA. He has been
aligned in working for sector reports of
various geographies along with market
sizing and forecasting.
Dr. Purav Gandhi
Founder & CEO
Mukesh Nayak
Head - Marketing
Ritu Baliya
Engagement Manager
Dhruv Joshi
Consultant
Project Leadership Team

7 years of experience working with leading organizations in pharma, MedTech
and healthcare domain. Some of our recent clients are mentioned below
… and many more

Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
Whatsapp: (+91) 931 639 7935
We would be happy to help.

Canada Over The Counter (OTC) Drugs Market Analysis Report 2022 to 2030

Recommended

Recommended

More Related Content

Similar to Canada Over The Counter (OTC) Drugs Market Analysis Report 2022 to 2030

Similar to Canada Over The Counter (OTC) Drugs Market Analysis Report 2022 to 2030 (20)

More from Insights10

More from Insights10 (20)

Recently uploaded

Recently uploaded (20)

Canada Over The Counter (OTC) Drugs Market Analysis Report 2022 to 2030